|Mr. Michael K. Sergesketter||Interim Executive Vice President, Chief Financial Officer & Treasurer||227,53k||N/A||1960|
|Dr. Stanislav Glezer M.D., MBA||Executive VP & CTO||575,8k||N/A||1973|
|Mr. Jason Somer||Executive VP, General Counsel & Corporate Secretary||409,92k||N/A||1968|
|Mr. Kevin R. Smith||President, CEO & Director||N/A||N/A||1971|
|Ms. Jennifer Yi Boyer||Executive VP & Chief Human Resources Officer||N/A||N/A||N/A|
|Mr. Vijay Paliwal||Senior Vice President of Enterprise Enablement||N/A||N/A||N/A|
|Mr. Matthew Pigeon||Investor Relations Officer||N/A||N/A||N/A|
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; and related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Inogen, Inc.s ISS Governance QualityScore, Stand 1. Dezember 2023, lautet 5. Die grundlegenden Scores sind Audit: 2, Vorstand: 5, Shareholderrechte: 8, Kompensation: 6.